Eisai Co - Company & Market Research Reports

Home /
Companies /
Eisai Co

Eisai Limited is a research-based pharmaceutical company that develops, manufactures, and markets healthcare products for patients and their families. It offers products in the areas of Alzheimer's disease, gastrointestinal disorders, epilepsy, cervical dystonia, severe chronic pain, and oncology. The company was founded in 1988 and is based in Hatfield, United Kingdom. It also has operations in the United States, Asia, and Europe.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 118
Oncology Drugs 117
Drug Discovery 65
Gastrointestinal Drugs 53
Clinical Trials 32
Alzheimer's Disease Drugs 30
Musculoskeletal Disorders Drugs 29
Pharmaceuticals 28
Liver Cancer Drugs 27
Cardiovascular Drugs 21
Infectious Diseases Drugs 21
Brain Cancer Drugs 21
Immune Disorders Drugs 20
Leukemia Drugs 18
Biopharmaceuticals 18
Breast Cancer Drugs 16
Lymphoma Drugs 15
Skin Cancer Drugs 12
Kidney Cancer Drugs 12
Endocrine and Metabolic Disorders Drugs 12
Drugs by Therapeutic Area 11
Anesthetic Drugs 11
Infusions and Injectables 10
Liver and Kidney Disorders Drugs 10
Drug Delivery 9
Colon Cancer Drugs 8
Analgesics 8
Hematological Drugs 8
Thyroid Cancer Drugs 8
Pharmaceutical Manufacturing 8
Lung Cancer Drugs 7
Uterine Cancer Drugs 7
Anti-Obesity Drugs 7
Ovarian Cancer Drugs 6
Bladder Cancer Drugs 6
Over the Counter (OTC) Drugs 6
Vitamins and Dietary Supplements 6
Respiratory Drugs 5
Company Reports 4
Optical Disorders Drugs 4
Mental Disorders Drugs 4
Dermatological Drugs 4
Pharmaceutical Intermediates 3
Cervical Cancer Drugs 3
Prostate Cancer Drugs 2
Biosimilars and Biosuperiors 2
Pancreatic Cancer Drugs 2
Sexual and Reproductive Health Drugs 2
Diabetes Drugs 1
Generic Drugs 1
Pharmacoeconomics 1
Vaccines 1
Psoriasis Drugs 1
Immunosuppressive Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



276 reviews

683 Results (Page 9 of 35)
- Relevance
  Sort by

Pontine Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
138 Pages
Global

From

€1975EUR$2,000USD£1,643GBP

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

 Report
February 2023
243 Pages
Asia Pacific

From

€5481EUR$5,550USD£4,561GBP

Recurrent Glioblastoma Multiforme (GBM) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

 Report
May 2022
548 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

Melanoma Therapeutics - Global Strategic Business Report

 Report
November 2024
162 Pages
Global

From

€5383EUR$5,450USD£4,478GBP

Alzheimer's Disease Therapeutics Market 2024-2028

 Report
November 2023
168 Pages
Global

From

€2469EUR$2,500USD£2,054GBP

NEED HELP FINDING THE RIGHT PRODUCT? Craig will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Lymphoma Therapeutics - Global Strategic Business Report

 Report
November 2024
406 Pages
Global

From

€5383EUR$5,450USD£4,478GBP

Non-Hodgkin Lymphoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
October 2022
1814 Pages
Global

From

€1975EUR$2,000USD£1,643GBP

Colorectal Cancer Drugs Market by Drug Class, Treatment Type, Route of Administration, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3501EUR$3,545USD£2,913GBP

€3890EUR$3,939USD£3,237GBP

Leukemia Therapeutics - Global Strategic Business Report

 Report
November 2024
193 Pages
Global

From

€4889EUR$4,950USD£4,068GBP

Alzheimer's Disease Therapeutics (2022 Edition) - Market Insight, Epidemiology and Pipeline Assessment (By Molecule Type, By Route of Administration, By Pipeline Phase)

 Report
October 2022
200 Pages
Global

From

€2370EUR$2,400USD£1,972GBP

Renal Cell Carcinoma: Global Drug Forecast and Market Analysis to 2028

 Report
February 2020
160 Pages
Global

From

€10859EUR$10,995USD£9,035GBP

B-Cell Chronic Lymphocytic Leukemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
April 2022
139 Pages
Global

From

€1975EUR$2,000USD£1,643GBP

Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
159 Pages
Global

From

€3457EUR$3,500USD£2,876GBP

Alzheimer Drugs Market (2022 Edition) - Analysis By Drug Class (Cholinergic, Memantine, Combined Drugs, Others), Distribution Channel, By Region, By Country: Market Insights, Pipeline and Forecast with Impact of Covid-19 (2022-2027)

 Report
January 2022
220 Pages
Global

From

€2370EUR$2,400USD£1,972GBP

Alzheimer's Disease: Pipeline Review, Developer Landscape and Competitive Insights

 Report
March 2019
220 Pages
Global

From

€2962EUR$2,999USD£2,464GBP

Metastatic Breast Cancer Treatment Market by Treatment Type, End User - Global Forecast 2025-2030

 Report
October 2024
190 Pages
Global

From

€3501EUR$3,545USD£2,913GBP

€3890EUR$3,939USD£3,237GBP

HPV Associated Disorders Global Market Report 2024

 Report
January 2024
200 Pages
Global

From

€4938EUR$5,000USD£4,109GBP

Alzheimer's Disease Diagnostics and Therapeutics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
117 Pages
Global

From

€4691EUR$4,750USD£3,903GBP

Gastrointestinal Stromal Tumor (GIST) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
November 2022
155 Pages
Global

From

€1975EUR$2,000USD£1,643GBP

Co-Development Deals in Pharmaceuticals and Biotechnology 2016 to 2024

 Report
September 2024
450 Pages
Global

From

€3946EUR$3,995USD£3,283GBP

683 Results (Page 9 of 35)
- 1
- 7
- 8
- 9
- 10
- 11

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.